Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miot-Noirault, E.
Right arrow Articles by Le Pape, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miot-Noirault, E.
Right arrow Articles by Le Pape, A.
(Chest. 2001;120:941-947.)
© 2001 American College of Chest Physicians

Scintigraphic In Vivo Assessment of the Development of Pulmonary Intravascular Macrophages in Liver Disease*

Experimental Study in Rats With Biliary Cirrhosis

Elisabeth Miot-Noirault, PhD; Laurence Faure, PhD; Yves Guichard, MD; Jérôme Montharu and Alain Le Pape, PhD

* From INSERM U484 (Dr. Miot-Noirault), Clermont-Ferrand Cédex; INSERM U316/EMI U0010 (Drs. Montharu and Le Pape), Tours; and MDS Pharma Services Europe (Drs. Faure and Guichard), Lyon, France.

Correspondence to: Elisabeth Miot-Noirault, PhD, INSERM U484, BP 184, Rue Montalembert, 63005 Clermont Ferrand Cédex, France; e-mail: noirault{at}inserm484.u-clermont1.fr

Study objectives: In regard to nuclear medicine literature reporting lung uptake of colloidal radiopharmaceuticals in patients with liver diseases, it has been hypothesized that liver abnormalities could trigger induction of pulmonary intravascular macrophages (PIMs) in humans normally lacking them. Recently, experimental induction of PIMs in rats in which they are not normally prevalent has been demonstrated to be at the origin of pulmonary hemodynamic alterations with an increased susceptibility to ARDS. If such induction may occur in humans, the risk of pulmonary hemodynamic alterations has to be considered and detected. This study demonstrates in a rodent model of biliary cirrhosis that scintigraphy of phagocytic function as commonly used for liver exploration is a suitable strategy for staging PIM development.

Design: Sixty rats were randomized as follows: bile duct section (n = 40), sham operation (n = 10), and no operation (n = 10). The rats were submitted to scintigraphy of phagocytic function every 5 days over 35 days for the assessment of radiocolloid uptake within lung and liver. At day 35, radioactivity of blood was counted and immunohistochemistry was performed on lung specimens.

Results: As disease progressed, radiopharmaceutical uptake decreased within the liver, while increasing considerably in the lung. At day 35, lung uptake averaged about 66% as compared to 3% before surgery. Lung histologic findings revealed numerous intravascular mononuclear cells closely related to the monocyte-macrophage lineage.

Conclusion: Scintigraphy of phagocytic function commonly used for liver scanning could be a suitable strategy for the diagnosis of the induction of PIMs under pathologic situations.

Key Words: biliary cirrhosis • pulmonary intravascular macrophages • pulmonary phagocytosis • rat • scintigraphy




This article has been cited by other articles:


Home page
Eur Respir JHome page
B. Sztrymf, A. Rabiller, H. Nunes, L. Savale, D. Lebrec, A. Le Pape, V. de Montpreville, M. Mazmanian, M. Humbert, and P. Herve
Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats
Eur. Respir. J., May 1, 2004; 23(5): 752 - 758.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Rabiller, H. Nunes, D. Lebrec, K. A. Tazi, M. Wartski, E. Dulmet, J.-M. Libert, C. Mougeot, R. Moreau, M. Mazmanian, et al.
Prevention of Gram-Negative Translocation Reduces the Severity of Hepatopulmonary Syndrome
Am. J. Respir. Crit. Care Med., August 15, 2002; 166(4): 514 - 517.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American College of Chest Physicians.